Podcast Episodes

Back to Search
Nicholas Investment Partners Dumps Abercrombie Shares
Nicholas Investment Partners Dumps Abercrombie Shares

Nicholas Investment Partners recently sold off over one hundred nine thousand shares of Abercrombie and Fitch, valued at ten point six five mill…

11 hours ago

Short Long
View Episode
Steady Energy Income: Enterprise Products Partners
Steady Energy Income: Enterprise Products Partners

Discover the stability of Enterprise Products Partners, an energy infrastructure company offering a consistent 5.7% yield and a 27-year track re…

11 hours ago

Short Long
View Episode
Bond Yields Spark Crypto Market Dip
Bond Yields Spark Crypto Market Dip

Dogecoin and other meme coins plummeted Friday as a surge in bond yields, driven by rising oil prices and inflation fears, led investors to pull…

11 hours ago

Short Long
View Episode
Steris Q1 2026: Resilient Growth & Bright Outlook
Steris Q1 2026: Resilient Growth & Bright Outlook

Steris Q1 2026 earnings meet expectations, with a 7.3% revenue increase to $1.59 billion and EPS of $2.83. The company focuses on healthcare and…

11 hours ago

Short Long
View Episode
Nicholas Investment Partners Backs Callaway Golf
Nicholas Investment Partners Backs Callaway Golf

Nicholas Investment Partners invests heavily in Callaway Golf, signaling confidence in the brands direction. Callaways stock surges, driven by s…

11 hours ago

Short Long
View Episode
Cadre's Q1: Record Backlog, Acquisitions, & Growth
Cadre's Q1: Record Backlog, Acquisitions, & Growth

Cadres Q1 2026 results show a significant revenue jump of 19.5% to $155.4 million, surpassing profit expectations with $0.18 per share. Despite …

11 hours ago

Short Long
View Episode
Insight Enterprises Q1 2026: AI-Driven Growth & Organic Focus
Insight Enterprises Q1 2026: AI-Driven Growth & Organic Focus

Insight Enterprises Q1 2026 earnings showcase impressive growth, surpassing analyst expectations with $2.13 billion in revenue and $2.88 in adju…

11 hours ago

Short Long
View Episode
Exelixis: Biotech's Billion-Dollar Bet
Exelixis: Biotech's Billion-Dollar Bet

Exelixis, a biotech firm, has delivered impressive stock market performance, outpacing the broader market with a 101% return over five years. An…

11 hours ago

Short Long
View Episode
Bitcoin Drops Amid Bond Yield Spike, Inflation Fears
Bitcoin Drops Amid Bond Yield Spike, Inflation Fears

Bitcoin plummeted over the weekend, losing nearly three percent by Fridays close, due to surging bond yields and geopolitical tensions. MicroStr…

11 hours ago

Short Long
View Episode
Inflation Hits Hard, Retail Sector Suffers
Inflation Hits Hard, Retail Sector Suffers

Market plummets as inflation soars, hitting retail and discretionary sectors; American Outdoor Brands stock dips due to sales drop and internal …

11 hours ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us